Cohausz & Florack wins Managing IP Award 2025 in the category “Germany Impact Case of the Year”
Award for outstanding performance in Federal Court of Justice landmark decision X ZR 104/22
Cohausz & Florack is “European Cross-Border Patent Litigation Team of the Year”
Managing IP Award 2025 recognizes the firm’s outstanding performance in the Bayer / Xarelto proceedings
Microsoft Faces HEVC Lawsuit in Germany
Strategic Enforcement of Standard-Essential Patents
Iconic – or even a work of art?
Federal Court of Justice denies copyright protection for Birkenstock sandals
EU Commission abandons SEP reform proposal and reinforces the EU’s quality as a court location
C&F welcomes the Commission’s commitment to consistent European case law
CFTalks: Patent Enforcement in Korea
Statistics, Overview, Comparison with Germany and Benefits/Challenges
Recording CFWebinar: EPO Case Law Update 2024/2025 - Chemistry, Pharma and Life Sciences
Recording from 11.02.2025
A&O SHEARMAN and COHAUSZ & FLORACK successful for Bayer in keeping generics off the German market
Higher Regional Court Munich upholds preliminary injunctions based on Bayer’s patent on the once-daily administration of rivaroxaban (Xarelto®)